Get started
Author

Christine Thurnheer

Observed names: C Thurnheer, C. Thurnheer, C.M. Thurnheer, Christine M. Thurnheer, Thurnheer, Christine
OpenAlex ID: A5113484713
CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells
2018 · Ayako Kurioka, Cormac Cosgrove, et al. · Frontiers in Immunology · 124
PDF
TheHCP5Single‐Nucleotide Polymorphism: A Simple Screening Tool for Prediction of Hypersensitivity Reaction to Abacavir
2008 · Sara Colombo, Andri Rauch, et al. · The Journal of Infectious Diseases · 95
PDF
Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection
2021 · Gail V. Matthews, Gail V. Matthews, et al. · Journal of Hepatology · 53
PDF
The Impact of Surgical Strategy and Rifampin on Treatment Outcome in Cutibacterium Periprosthetic Joint Infections
2020 · Katharina Kusejko, Álvaro Auñón, et al. · Clinical Infectious Diseases · 45
PDF
Gender inequalities in the response to combination antiretroviral therapy over time: the S wiss HIV C ohort S tudy
2014 · C Rosin, L Elzi, et al. · HIV Medicine · 36
PDF
Refining Abacavir Hypersensitivity Diagnoses using a Structured Clinical Assessment and Genetic Testing in the Swiss HIV Cohort Study
2008 · Andri Rauch, David Nolan, et al. · Antiviral Therapy · 35
PDF
Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Κb Activation
2012 · Emilie Zuercher, Christophe Butticaz, et al. · PLoS ONE · 23
PDF
Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study
2017 · J. Grebely, O. Dalgard, et al. · Journal of Hepatology · 20
Trueperella pyogenes endocarditis in a Swiss farmer: a case report and review of the literature
2023 · Johann Stuby, Patrizia Lardelli, et al. · BMC Infectious Diseases · 16
PDF
Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
2021 · Isabella C Schoepf, Christian W Thorball, et al. · Clinical Infectious Diseases · 15
PDF
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years
2021 · Isabella C Schoepf, Christian W Thorball, et al. · The Journal of Infectious Diseases · 14
PDF
Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic
2022 · Olivier Schorr, Sarah Blach, et al. · PLoS ONE · 1
PDF
29 Antiviral drugs
2007 · Christoph Fux, John Evison, et al. · Side effects of drugs annual · 1
Ageing with addiction: Describing health conditions of younger and older drug users in Switzerland
2019 · Alberto Moriggia, Paola Di Giulio, et al.
CD161 defines a functionally distinct subset of pro-inflammatory natural killer cells
2018 · Ayako Kurioka, Cormac Cosgrove, et al. · Newcastle University ePrints (Newcastle Univesity)
P0848 : Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCV genotype 2/3 infection: The activate study
2015 · J. Grebely, O. Dalgard, et al. · Journal of Hepatology
Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation
2012 · Zuercher, Emilie, Butticaz, Christophe, et al. · Zurich Open Repository and Archive (University of Zurich)
Genetic testing and a structured clinical assessment reveal overdiagnosis of abacavir hypersensitivity reactions in the Swiss HIV Cohort study
2008 · Angelika Rauch, Christine Thurnheer, et al. · Murdoch University Research Portal
Works count: 21
Citation count: 479
H-index: 11
I10-index: 11
Year
Topic
Type